首页> 美国卫生研究院文献>ACS Medicinal Chemistry Letters >Discovery and StructuralModification of 1-Phenyl-3-(1-phenylethyl)urea Derivatives as Inhibitorsof Complement
【2h】

Discovery and StructuralModification of 1-Phenyl-3-(1-phenylethyl)urea Derivatives as Inhibitorsof Complement

机译:发现与结构1-苯基-3-(1-苯乙基)脲衍生物作为抑制剂的改性补数

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of 1-phenyl-3-(1-phenylethyl)urea derivatives were identified as novel and potent complement inhibitors through structural modification of the original compound from high-throughput screening. Various analogues (>7 and >13–>15) were synthesized and identified as complement inhibitors, with the introduction of a five- or six-carbon chain (>7c, >7d, >7k, >7l, and >7o) greatly improving their activity. Optimized compound >7l has an excellent inhibition activity with IC50 values as low as 13 nM. We demonstrated that the compound >7l inhibited C9 deposition through the classical, the lectin, and the alternative pathways but had no influence on C3 and C4 depositions.
机译:通过高通量筛选对原始化合物进行结构修饰,确定了一系列1-苯基-3-(1-苯基乙基)脲衍生物是新型有效的补体抑制剂。合成了多种类似物(> 7 和> 13 – > 15 )并鉴定为补体抑制剂,并引入了五碳或六碳链(> 7c ,> 7d ,> 7k ,> 7l 和> 7o )极大地改善了他们的活动。优化的化合物> 7l 具有出色的抑制活性,IC50值低至13 nM。我们证明了化合物> 7l 通过经典途径,凝集素和替代途径抑制了C9沉积,但对C3和C4沉积没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号